SCHEMBL13626122

SCHEMBL13626122

CCc1sc(C(=O)Nc2c(F)ccc(-c3cn(C)c(=O)c(Nc4ccc(N5CCN(C)CC5)cc4)n3)c2F)cc1C(C)C

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626829 0.94 BTK (0.55) BTK
SCHEMBL13626131 0.89 BTK (0.43) BTK
SCHEMBL13626472 0.87 BTK (0.55) BTK
SCHEMBL13626128 0.87 BTK (0.41) BTK
SCHEMBL13626189 0.85 BTK (0.52) BTK
SCHEMBL13626824 0.84 BTK (0.48) BTK
SCHEMBL13626184 0.84 BTK (0.48) BTK
SCHEMBL13626828 0.83 BTK (0.43) BTK
SCHEMBL12651118 0.81 BTK (0.56) BTK
SCHEMBL13626375 0.80 BTK (0.52) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009137596-A1 SUBSTITUTED AMIDES, METHOD OF MAKING, AND USE AS BTK INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed